Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Acta Radiologica 59.10 (2018): 1149 - 1156.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2018
- Urheber
-
Goertz, Ruediger S.
Klett, Daniel
Wildner, Dane
Atreya, Raja
Neurath, Markus F.
Strobel, Deike
- DOI
-
10.1177/0284185117752032
- URN
-
urn:nbn:de:bvb:29-opus4-135513
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goertz, Ruediger S.
- Klett, Daniel
- Wildner, Dane
- Atreya, Raja
- Neurath, Markus F.
- Strobel, Deike
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2018
Ähnliche Objekte (12)
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Role of the IL23/IL17 Pathway in Crohn’s Disease
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Role of the IL23/IL17 Pathway in Crohn’s Disease
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Role of the IL23/IL17 Pathway in Crohn’s Disease
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?